Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

Could Cosentyx free psoriasis patients from treatment?

Could Cosentyx free psoriasis patients from treatment? in the US last March and Valeant's Siliq (brodalumab) which got its first green light in February.

BMS appoints three independent directors

BMS appoints three independent directors Robert Bertolini brings strategic and operational leadership experience from Bausch &Lomb, where he recently served as president and chief financial officer prior to the company's sale to Valeant.

FDA OKs Valeant's psoriasis drug Siliq, with black box warning

FDA OKs Valeant's psoriasis drug Siliq, with black box warning Valeant got an FDA green light for its psoriasis drug Siliq yesterday, but with a warning that it has been linked to suicidal thoughts. ... The approval comes after a three-month extension to the review period that was intended to allow Valeant and the

Deal Watch January 2017

Deal Watch January 2017 Bringing in an additional $819.9m in cash, Valeant also sold its equity interest in Dendreon (manufacturer of Provenge, a personalised immunotherapy) to the Sanpower Group. ... 1, 600. Valeant. L'Oreal. Divestment. CeraVe AcneFree AMBI. 1, 300. Forward

Valeant uncouples Dendreon and skincare brands to cut debt

Valeant uncouples Dendreon and skincare brands to cut debt Canada's Valeant has agreed to sell off assets in two deals worth $2.1bn as it works to pay down high levels of debt. ... Valeant had also been trying to sell its Salix gastrointestinal drugs unit to Japan's Takeda for towards the end of last year, but

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics